Urso 250 and Uniphyl drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Urso 250 (ursodiol) and Uniphyl (theophylline). Common drug interactions include leukocytoclastic vasculitis among females and blood bilirubin increased among males.
The phase IV clinical study analyzes what interactions people have when they take Urso 250 and Uniphyl. It is created by eHealthMe based on reports of 30 people who take the same drugs from the FDA, and is updated regularly.
What is Urso 250?
Urso 250 has active ingredients of ursodiol. eHealthMe is studying from 5,080 Urso 250 users. Check the latest studies of Urso 250.
What is Uniphyl?
Uniphyl has active ingredients of theophylline. eHealthMe is studying from 3,086 Uniphyl users. Check the latest studies of Uniphyl.
30 people who take Urso 250 and Uniphyl together, and have interactions are studied.

What are the common drug interactions of Urso 250 and Uniphyl, by gender? *:
female:
- Leukocytoclastic vasculitis (inflammation of small blood vessels (usually post-capillary venules in the dermis), characterized by palpable purpura)
- Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
- Allergic granulomatous angiitis (allergic inflammation of a blood vessel or lymph duct)
- Vasculitis (inflammation of a blood vessel or blood vessels)
- Nephritis interstitial (a kidney condition characterized by swelling in between the kidney tubules)
- Anorexia (eating disorder characterized by immoderate food restriction and irrational fear of gaining weight)
- Asthma
- Cerebral infarction (less blood supply to brain resulting tissue damage)
- Haematuria (presence of blood in urine)
- Malaise (a feeling of general discomfort or uneasiness)
male:
- Blood bilirubin increased
- Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
- Blood creatinine increased
- Blood pressure diastolic increased
- Disease progression
- Gamma-glutamyltransferase increased
- Graft versus host disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body)
- Obliterative bronchiolitis (bronchiolar inflammation)
- Pleurisy (inflammation of the pleurae, which causes pain when breathing)
- Sepsis (a severe blood infection that can lead to organ failure and death)
What are the common drug interactions of Urso 250 and Uniphyl, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
- Blood bilirubin increased
- Graft versus host disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body)
- Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
- Obliterative bronchiolitis (bronchiolar inflammation)
- Pseudomonas infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa)
- Sepsis (a severe blood infection that can lead to organ failure and death)
30-39:
n/a
40-49:
n/a
50-59:
- Anaemia (lack of blood)
- Aplasia pure red cell (type of anaemia affecting the precursors to red blood cells but not to white blood cells)
60+:
- Leukocytoclastic vasculitis (inflammation of small blood vessels (usually post-capillary venules in the dermis), characterized by palpable purpura)
- Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
- Nephropathy (damage to or disease of a kidney)
- Nephrotic syndrome (kidney disease with proteinuria, hypoalbuminemia, and oedema)
- Proteinuria (presence of protein in the urine)
- Rhinitis allergic (inflammation of the nasal airways due to allergy)
- Altered state of consciousness (altered state of mind)
- Autoimmune thrombocytopenia (isolated low platelet count (thrombocytopenia) with normal bone marrow and the absence of other causes of thrombocytopenia)
- Cough
- Fall
What are the existing conditions these people have? *
- Asthma: 19 people, 63.33%
- Gallstones (stone formation by bile component): 17 people, 56.67%
- High Blood Pressure: 15 people, 50.00%
- Allergic Rhinitis: 15 people, 50.00%
- Cerebral Infarction (less blood supply to brain resulting tissue damage): 10 people, 33.33%
- Hepatitis C: 5 people, 16.67%
- Back Pain: 4 people, 13.33%
- Hyperuricaemia (level of uric acid in the blood that is abnormally high): 3 people, 10.00%
- Gastritis (inflammation of stomach): 3 people, 10.00%
- Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 3 people, 10.00%
* Approximation only. Some reports may have incomplete information.
Do you take Urso 250 and Uniphyl?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Urso 250 and Uniphyl:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Urso 250:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Uniphyl:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Urso 250 and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Uniphyl and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Korang-Yeboah M, Rahman Z, Shah D, Mohammad A, Wu S, Siddiqui A, Khan MA, "Impact of formulation and process variables on solid-state stability of theophylline in controlled release formulations", International journal of pharmaceutics, 2016 Feb .
- Dhaval MK, "Impact of formulation and process variables on solid-state stability of theophylline in controlled release formulations", International Journal of Pharmaceutics, 2016 Jan .
- Korang-Yeboah M, Rahman Z, Shah D, Mohammad A, Wu S, Siddiqui A, Khan MA, "Impact of formulation and process variables on solid-state stability of theophylline in controlled release formulations", International journal of pharmaceutics, 2016 Feb .
- Dhaval MK, "Impact of formulation and process variables on solid-state stability of theophylline in controlled release formulations", International Journal of Pharmaceutics, 2016 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on ursodiol and theophylline (the active ingredients of Urso 250 and Uniphyl, respectively), and Urso 250 and Uniphyl (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Toviaz cause Dizziness? - 3 seconds ago
- Could Fenofibrate cause Enterobacter Infection? - 6 seconds ago
- Drug interactions of Moxifloxacin and Cosopt - 10 seconds ago
- Could Celebrex cause Bell'S Palsy? - 13 seconds ago
- Could Benicar cause Vaginal Bleeding? - 14 seconds ago
- Macular Degeneration and Heart Rate Decreased - 15 seconds ago
- Could Triamcinolone Acetonide cause Anti-Cyclic Citrullinated Peptide Antibody Positive? - 20 seconds ago
- Could Prochlorperazine cause Paroxysmal Supraventricular Tachycardia? - 24 seconds ago
- Could Eprex cause Dry Mouth? - 24 seconds ago
- Drug interactions of Videx Ec and Aspirin - 28 seconds ago